Scivanta Medical Corp (SCVM) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
215 MORRIS AVENUE SPRING LAKE, NJ 07762 |
| State of Incorp. | DE |
| Fiscal Year End | October 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 7/31/2016 MRQ | 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 21,658 | 26,114 | 19,908 | 64,325 | |||
| Cash and cash equivalent | 21,658 | 26,114 | 19,908 | 64,325 | |||
| Prepaid expense | 6,969 | 6,673 | 12,018 | ✕ | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 9,543 | ||
| Total current assets: | 28,627 | 32,787 | 31,926 | 73,868 | |||
| Noncurrent Assets | |||||||
| TOTAL ASSETS: | 28,627 | 32,787 | 31,926 | 73,868 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 221,132 | 163,199 | 256,972 | 312,888 | |||
| Accounts payable | 102,086 | 101,055 | 215,584 | 222,845 | |||
| Accrued liabilities | 119,046 | 62,144 | 41,388 | 90,043 | |||
| Debt | 694,791 | 617,262 | 304,615 | 130,000 | |||
| Due to related parties | 369,479 | 211,898 | |||||
| Other undisclosed current liabilities | 96,659 | 308,278 | |||||
| Total current liabilities: | 1,285,402 | 992,359 | 658,246 | 751,166 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 105,000 | 105,000 | 205,000 | 375,000 | |||
| Long-term debt, excluding current maturities | 105,000 | 105,000 | 205,000 | 375,000 | |||
| Liabilities, other than long-term debt | 105,000 | ||||||
| Due to related parties | 105,000 | ||||||
| Other undisclosed noncurrent liabilities | (105,000) | ||||||
| Total noncurrent liabilities: | 105,000 | 105,000 | 205,000 | 375,000 | |||
| Total liabilities: | 1,390,402 | 1,097,359 | 863,246 | 1,126,166 | |||
| Equity | |||||||
| Equity, attributable to parent | (1,361,775) | (1,064,572) | (831,320) | (1,052,298) | |||
| Common stock | 6,359 | 6,359 | 5,429 | 31,117 | |||
| Additional paid in capital | 23,080,594 | 23,070,589 | 22,880,390 | 22,343,225 | |||
| Accumulated deficit | (24,448,728) | (24,141,520) | (23,717,139) | (23,426,640) | |||
| Total equity: | (1,361,775) | (1,064,572) | (831,320) | (1,052,298) | |||
| TOTAL LIABILITIES AND EQUITY: | 28,627 | 32,787 | 31,926 | 73,868 | |||
Income Statement (P&L) (USD)
| 7/31/2016 TTM | 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|---|
| Cost of product and service sold | (135,000) | |||||
| Financial services costs | (54) | (643) | ||||
| Gross profit: | (54) | (135,643) | ||||
| Operating expenses | (236,273) | (426,168) | (257,790) | (254,174) | ||
| Other undisclosed operating income | 80,710 | 135,643 | ||||
| Operating loss: | (236,273) | (345,512) | (257,790) | (254,174) | ||
| Nonoperating expense (Other Nonoperating expense) | (21,750) | |||||
| Interest and debt expense | (70,935) | (78,869) | (32,709) | (27,195) | ||
| Loss from continuing operations: | (307,208) | (424,381) | (290,499) | (303,119) | ||
| Loss before gain (loss) on sale of properties: | (307,208) | (424,381) | (290,499) | (303,119) | ||
| Net loss available to common stockholders, basic: | (307,208) | (424,381) | (290,499) | (303,119) | ||
| Interest on convertible debt | (12,534) | (29,058) | ||||
| Net loss available to common stockholders, diluted: | (319,742) | (453,439) | (290,499) | (303,119) | ||
Comprehensive Income (USD)
| 7/31/2016 TTM | 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|---|
| Net loss: | (307,208) | (424,381) | (290,499) | (303,119) | ||
| Comprehensive loss, net of tax, attributable to parent: | (307,208) | (424,381) | (290,499) | (303,119) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.